ReachMD

Episodes 1-4 of 4

• • 

    

    Kevan C. Herold, MD

    Peer

  • 

    

    Chantal Mathieu, MD, PhD

    Peer

  0

  

  RestartResume

  Type 1 Diabetes & the Role of Anti-CD3 Targeted Therapy

  Type 1 Diabetes & the Role of Anti-CD3 Targeted Therapy

  0.50 credits

• • 

    

    Janet B. McGill, MD, MA, FACE, FACP

    Peer

  • 

    

    John J. Russell, MD

    Peer

  13

  

  RestartResume

  At the Crossroad of Care: New Advances in Diabetic Kidney Disease

  At the Crossroad of Care: New Advances in Diabetic Kidney Disease

  0.50 credits

• • 

    

    Eliot Brinton, MD, FAHA, FNLA

    Peer

  • 

    

    Erin D. Michos, MD, MHS, FACC, FAHA, FASE

    Peer

  20

  

  RestartResume

  The New Role of Omega-3 Fatty Acids in Reducing ASCVD Risk in Women: Expert Dialogue

  The New Role of Omega-3 Fatty Acids in Reducing ASCVD Risk in Women: Expert Dialogue

  0.75 credits

• • 

    

    Christopher P. Cannon, MD

    Peer

  • 

    

    Samuel Dagogo-Jack, MD, DSc

    Peer

  12

  

  RestartResume

  Is It Time to Change Your Treatment Strategy for Type 2 Diabetes Patients with CV Risks?

  Is It Time to Change Your Treatment Strategy for Type 2 Diabetes Patients with CV Risks?

  0.25 credits